|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 32895 |
FusionGeneSummary for SCRN2_CBX1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: SCRN2_CBX1 | Fusion gene ID: 32895 | Hgene | Tgene | Gene symbol | SCRN2 | CBX1 | Gene ID | 90507 | 10951 |
| Gene name | secernin 2 | chromobox 1 | |
| Synonyms | Ses2 | CBX|HP1-BETA|HP1Hs-beta|HP1Hsbeta|M31|MOD1|p25beta | |
| Cytomap | 17q21.32 | 17q21.32 | |
| Type of gene | protein-coding | protein-coding | |
| Description | secernin-2 | chromobox protein homolog 1HP1 beta homologchromobox homolog 1 (HP1 beta homolog Drosophila )heterochromatin protein 1 homolog betaheterochromatin protein 1-betaheterochromatin protein p25 betamodifier 1 protein | |
| Modification date | 20180523 | 20180522 | |
| UniProtAcc | Q96FV2 | P83916 | |
| Ensembl transtripts involved in fusion gene | ENST00000407215, ENST00000290216, ENST00000584123, | ENST00000393408, ENST00000225603, ENST00000495350, | |
| Fusion gene scores | * DoF score | 4 X 2 X 4=32 | 4 X 2 X 4=32 |
| # samples | 4 | 4 | |
| ** MAII score | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: SCRN2 [Title/Abstract] AND CBX1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | UCEC | TCGA-EY-A4KR-01A | SCRN2 | chr17 | 45918036 | - | CBX1 | chr17 | 46152462 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000407215 | ENST00000393408 | SCRN2 | chr17 | 45918036 | - | CBX1 | chr17 | 46152462 | - |
| Frame-shift | ENST00000407215 | ENST00000225603 | SCRN2 | chr17 | 45918036 | - | CBX1 | chr17 | 46152462 | - |
| Frame-shift | ENST00000407215 | ENST00000495350 | SCRN2 | chr17 | 45918036 | - | CBX1 | chr17 | 46152462 | - |
| Frame-shift | ENST00000290216 | ENST00000393408 | SCRN2 | chr17 | 45918036 | - | CBX1 | chr17 | 46152462 | - |
| Frame-shift | ENST00000290216 | ENST00000225603 | SCRN2 | chr17 | 45918036 | - | CBX1 | chr17 | 46152462 | - |
| Frame-shift | ENST00000290216 | ENST00000495350 | SCRN2 | chr17 | 45918036 | - | CBX1 | chr17 | 46152462 | - |
| In-frame | ENST00000584123 | ENST00000393408 | SCRN2 | chr17 | 45918036 | - | CBX1 | chr17 | 46152462 | - |
| In-frame | ENST00000584123 | ENST00000225603 | SCRN2 | chr17 | 45918036 | - | CBX1 | chr17 | 46152462 | - |
| In-frame | ENST00000584123 | ENST00000495350 | SCRN2 | chr17 | 45918036 | - | CBX1 | chr17 | 46152462 | - |
Top |
FusionProtFeatures for SCRN2_CBX1 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| SCRN2 | CBX1 |
| Component of heterochromatin. Recognizes and bindshistone H3 tails methylated at 'Lys-9', leading to epigeneticrepression. Interaction with lamin B receptor (LBR) can contributeto the association of the heterochromatin with the inner nuclearmembrane. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for SCRN2_CBX1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| >In-frame_SCRN2_ENST00000584123_chr17_45918036_-_CBX1_ENST00000393408_chr17_46152462_-_146aa MERPASPQMASSSPDSPCSCDCFVSVPPASAIPAVIFAKNSDRPRDEVQEVVFVPAGTHTPGSRLQSEKPRGFARGLEPERIIGATDSSG >In-frame_SCRN2_ENST00000584123_chr17_45918036_-_CBX1_ENST00000225603_chr17_46152462_-_146aa MERPASPQMASSSPDSPCSCDCFVSVPPASAIPAVIFAKNSDRPRDEVQEVVFVPAGTHTPGSRLQSEKPRGFARGLEPERIIGATDSSG >In-frame_SCRN2_ENST00000584123_chr17_45918036_-_CBX1_ENST00000495350_chr17_46152462_-_99aa MERPASPQMASSSPDSPCSCDCFVSVPPASAIPAVIFAKNSDRPRDEVQEVVFVPAGTHTPGSRLQSEKPRGFARGLEPERIIGATDSSG |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| >In-frame_SCRN2_ENST00000584123_chr17_45918036_-_CBX1_ENST00000393408_chr17_46152462_-_438nt ATGGAGAGGCCCGCCTCTCCCCAGATGGCGTCGTCGAGCCCTGACTCCCCATGTTCCTGCGACTGCTTTGTCTCCGTGCCCCCGGCCTCA GCCATCCCGGCTGTGATCTTTGCCAAGAACTCGGACCGACCCCGGGACGAGGTGCAGGAGGTGGTGTTTGTCCCCGCAGGCACTCACACT CCTGGGAGCCGGCTCCAGTCAGAAAAGCCACGAGGCTTTGCTCGAGGTTTGGAGCCGGAGCGGATTATTGGAGCTACAGACTCCAGTGGA GAGCTCATGTTCCTGATGAAATGGAAAAACTCTGATGAGGCTGACCTGGTCCCTGCCAAGGAAGCCAATGTCAAGTGCCCACAGGTTGTC >In-frame_SCRN2_ENST00000584123_chr17_45918036_-_CBX1_ENST00000225603_chr17_46152462_-_438nt ATGGAGAGGCCCGCCTCTCCCCAGATGGCGTCGTCGAGCCCTGACTCCCCATGTTCCTGCGACTGCTTTGTCTCCGTGCCCCCGGCCTCA GCCATCCCGGCTGTGATCTTTGCCAAGAACTCGGACCGACCCCGGGACGAGGTGCAGGAGGTGGTGTTTGTCCCCGCAGGCACTCACACT CCTGGGAGCCGGCTCCAGTCAGAAAAGCCACGAGGCTTTGCTCGAGGTTTGGAGCCGGAGCGGATTATTGGAGCTACAGACTCCAGTGGA GAGCTCATGTTCCTGATGAAATGGAAAAACTCTGATGAGGCTGACCTGGTCCCTGCCAAGGAAGCCAATGTCAAGTGCCCACAGGTTGTC >In-frame_SCRN2_ENST00000584123_chr17_45918036_-_CBX1_ENST00000495350_chr17_46152462_-_297nt ATGGAGAGGCCCGCCTCTCCCCAGATGGCGTCGTCGAGCCCTGACTCCCCATGTTCCTGCGACTGCTTTGTCTCCGTGCCCCCGGCCTCA GCCATCCCGGCTGTGATCTTTGCCAAGAACTCGGACCGACCCCGGGACGAGGTGCAGGAGGTGGTGTTTGTCCCCGCAGGCACTCACACT CCTGGGAGCCGGCTCCAGTCAGAAAAGCCACGAGGCTTTGCTCGAGGTTTGGAGCCGGAGCGGATTATTGGAGCTACAGACTCCAGTGGA |
| * Fusion transcript sequences (Full-length transcript). |
| >In-frame_SCRN2_ENST00000584123_chr17_45918036_-_CBX1_ENST00000393408_chr17_46152462_-_2127nt GTTGGACAGAAGAGGGTCGGGTATCTGGGCATGCGCAGGGCCGCAGGACTCTTGGTGGGGTAGCGAGGGGGACGGTCCCACGACTGCTCC GAAGGGCCGGGACTCCCAGTGGGGGCGGGACCCCCGGAGTGCCCGCCTGCGGACTCCCAAGCCTGGAGCCTGGGGAGAGGGTGGGCACCT CCGTTCCCGCACACCCGTCCATGGTGTGTGCGCCGAGCGTCCAGGAGCCACGGCGGTGTCTTCCTTGCGCGTCTTTTACACGTGTGGGGG TAGGCTGCTCCTCGGGGCTGAGCCGTGGCCAGGGTTATGGAGAGGCCCGCCTCTCCCCAGATGGCGTCGTCGAGCCCTGACTCCCCATGT TCCTGCGACTGCTTTGTCTCCGTGCCCCCGGCCTCAGCCATCCCGGCTGTGATCTTTGCCAAGAACTCGGACCGACCCCGGGACGAGGTG CAGGAGGTGGTGTTTGTCCCCGCAGGCACTCACACTCCTGGGAGCCGGCTCCAGTCAGAAAAGCCACGAGGCTTTGCTCGAGGTTTGGAG CCGGAGCGGATTATTGGAGCTACAGACTCCAGTGGAGAGCTCATGTTCCTGATGAAATGGAAAAACTCTGATGAGGCTGACCTGGTCCCT GCCAAGGAAGCCAATGTCAAGTGCCCACAGGTTGTCATATCCTTCTATGAGGAAAGGCTGACGTGGCATTCCTACCCCTCGGAGGATGAT GACAAAAAAGATGACAAGAACTAACGCTCCTGAGTACCAGCCCCTGTCACATCTGACTGTGGGTTTCAAGTGGGAAGGGAAGGAGTTCTA CTTGTCTTGACACCATAGAGGTGGCTTGAGAAGATGTCCTTTGAAGAGCCAGTATAGTTTCTGTGCCCTGCAGCAGCCCAAGTGCTTTAA AGCCGTTTCAAGCTGTATAGTTTGCACACCCATCCCAGTGGAGGGGAAAGGGGATAAGTGTTTCAAGGCAACCTTTTCTGCACTTTGCTG CGAAAAGCAAAGGGCCTTCTATGAAGGACAAAACTTGCAGAATTGGGTGTGTGGGAGAGCAAAAAAATACTGTAGATCTTCAAAGAGCAT CTCCACAACCCACAGCCTTCTTCCCAATAGTGTTAACTCTGCATTTTTACAGCGTAGCATGTGTGTAGTTTTTGGCTATTACTGGTGTAT TATTTGGGGGAGGGAGGGATGGGGAGGGGAGAAAGGGAGATGGGTAGCATCATTTTGATTAACATTTGGGGCCTGATAGGGGAAATGGTG AAGCAATGGAAAAGAACAGACAACTAATGATTTGCTTCTATGTCCAGAATATTTTACCTTTAAAAAAATGTCATTGGCACCATAAATAAG GACTGTGAGAGACTGTTTAAAAGCTGTGAAAGTCTGAAACCTATAAGCCAAGGTGTTCCCTGCCTAAACTTATTGCTGTTCCCACAAAGG ACTAAGCCTGTTCATAAGTTACCAAAGTTGCCATTTTGGAGATGGAAATTGACGAGGAGGGAAGGTCTTTTATTGGAGAGTATACAGTAC AAGCAGATCATTCTGCCTTAGAGGTGCTAATTCCCGAAATTAGAAGACCCTTTCTTTTCCAGTAACGAAGTTATAAATATCAGCTTGTTC ATCCAAGCCACTGGCTGAGGTGTTAGGAAGAGGAAGAGGGTGGTAGAGGAGGTAAGACAGTAGGGAAAGACAAGGGCCCATGCTCTTAGT GGGGAAAACTCTTGGAGCCGTTTACTTTGAGCTTTGAACACTGAAACCATTGTTGGCAGGGTTCAGTCACTGACAGCACAAGTTTCACTG AATTGATCCAAGAGTTTAGTGATTTCAAAAGCCTTGGTCTCAGGAGAAGATTAAACTTTCATATTGGGCAGTGGTTCACTTTAAAACACA CACATACACACACAAAACAATTTTTTAAGAAATCCTAATAAGTAACATACCCAAAATGCTCTGTCTTGAGTCATGAGAACCATCAGTTCT TGATATTGTCTAGACTTGCATCTAGAGCTACGTTGTAAAATTCTTTTAGGCATGTGTTAGATTTCTGTGTAAACTTTGTTTAAATGTAAA >In-frame_SCRN2_ENST00000584123_chr17_45918036_-_CBX1_ENST00000225603_chr17_46152462_-_2127nt GTTGGACAGAAGAGGGTCGGGTATCTGGGCATGCGCAGGGCCGCAGGACTCTTGGTGGGGTAGCGAGGGGGACGGTCCCACGACTGCTCC GAAGGGCCGGGACTCCCAGTGGGGGCGGGACCCCCGGAGTGCCCGCCTGCGGACTCCCAAGCCTGGAGCCTGGGGAGAGGGTGGGCACCT CCGTTCCCGCACACCCGTCCATGGTGTGTGCGCCGAGCGTCCAGGAGCCACGGCGGTGTCTTCCTTGCGCGTCTTTTACACGTGTGGGGG TAGGCTGCTCCTCGGGGCTGAGCCGTGGCCAGGGTTATGGAGAGGCCCGCCTCTCCCCAGATGGCGTCGTCGAGCCCTGACTCCCCATGT TCCTGCGACTGCTTTGTCTCCGTGCCCCCGGCCTCAGCCATCCCGGCTGTGATCTTTGCCAAGAACTCGGACCGACCCCGGGACGAGGTG CAGGAGGTGGTGTTTGTCCCCGCAGGCACTCACACTCCTGGGAGCCGGCTCCAGTCAGAAAAGCCACGAGGCTTTGCTCGAGGTTTGGAG CCGGAGCGGATTATTGGAGCTACAGACTCCAGTGGAGAGCTCATGTTCCTGATGAAATGGAAAAACTCTGATGAGGCTGACCTGGTCCCT GCCAAGGAAGCCAATGTCAAGTGCCCACAGGTTGTCATATCCTTCTATGAGGAAAGGCTGACGTGGCATTCCTACCCCTCGGAGGATGAT GACAAAAAAGATGACAAGAACTAACGCTCCTGAGTACCAGCCCCTGTCACATCTGACTGTGGGTTTCAAGTGGGAAGGGAAGGAGTTCTA CTTGTCTTGACACCATAGAGGTGGCTTGAGAAGATGTCCTTTGAAGAGCCAGTATAGTTTCTGTGCCCTGCAGCAGCCCAAGTGCTTTAA AGCCGTTTCAAGCTGTATAGTTTGCACACCCATCCCAGTGGAGGGGAAAGGGGATAAGTGTTTCAAGGCAACCTTTTCTGCACTTTGCTG CGAAAAGCAAAGGGCCTTCTATGAAGGACAAAACTTGCAGAATTGGGTGTGTGGGAGAGCAAAAAAATACTGTAGATCTTCAAAGAGCAT CTCCACAACCCACAGCCTTCTTCCCAATAGTGTTAACTCTGCATTTTTACAGCGTAGCATGTGTGTAGTTTTTGGCTATTACTGGTGTAT TATTTGGGGGAGGGAGGGATGGGGAGGGGAGAAAGGGAGATGGGTAGCATCATTTTGATTAACATTTGGGGCCTGATAGGGGAAATGGTG AAGCAATGGAAAAGAACAGACAACTAATGATTTGCTTCTATGTCCAGAATATTTTACCTTTAAAAAAATGTCATTGGCACCATAAATAAG GACTGTGAGAGACTGTTTAAAAGCTGTGAAAGTCTGAAACCTATAAGCCAAGGTGTTCCCTGCCTAAACTTATTGCTGTTCCCACAAAGG ACTAAGCCTGTTCATAAGTTACCAAAGTTGCCATTTTGGAGATGGAAATTGACGAGGAGGGAAGGTCTTTTATTGGAGAGTATACAGTAC AAGCAGATCATTCTGCCTTAGAGGTGCTAATTCCCGAAATTAGAAGACCCTTTCTTTTCCAGTAACGAAGTTATAAATATCAGCTTGTTC ATCCAAGCCACTGGCTGAGGTGTTAGGAAGAGGAAGAGGGTGGTAGAGGAGGTAAGACAGTAGGGAAAGACAAGGGCCCATGCTCTTAGT GGGGAAAACTCTTGGAGCCGTTTACTTTGAGCTTTGAACACTGAAACCATTGTTGGCAGGGTTCAGTCACTGACAGCACAAGTTTCACTG AATTGATCCAAGAGTTTAGTGATTTCAAAAGCCTTGGTCTCAGGAGAAGATTAAACTTTCATATTGGGCAGTGGTTCACTTTAAAACACA CACATACACACACAAAACAATTTTTTAAGAAATCCTAATAAGTAACATACCCAAAATGCTCTGTCTTGAGTCATGAGAACCATCAGTTCT TGATATTGTCTAGACTTGCATCTAGAGCTACGTTGTAAAATTCTTTTAGGCATGTGTTAGATTTCTGTGTAAACTTTGTTTAAATGTAAA >In-frame_SCRN2_ENST00000584123_chr17_45918036_-_CBX1_ENST00000495350_chr17_46152462_-_679nt GTTGGACAGAAGAGGGTCGGGTATCTGGGCATGCGCAGGGCCGCAGGACTCTTGGTGGGGTAGCGAGGGGGACGGTCCCACGACTGCTCC GAAGGGCCGGGACTCCCAGTGGGGGCGGGACCCCCGGAGTGCCCGCCTGCGGACTCCCAAGCCTGGAGCCTGGGGAGAGGGTGGGCACCT CCGTTCCCGCACACCCGTCCATGGTGTGTGCGCCGAGCGTCCAGGAGCCACGGCGGTGTCTTCCTTGCGCGTCTTTTACACGTGTGGGGG TAGGCTGCTCCTCGGGGCTGAGCCGTGGCCAGGGTTATGGAGAGGCCCGCCTCTCCCCAGATGGCGTCGTCGAGCCCTGACTCCCCATGT TCCTGCGACTGCTTTGTCTCCGTGCCCCCGGCCTCAGCCATCCCGGCTGTGATCTTTGCCAAGAACTCGGACCGACCCCGGGACGAGGTG CAGGAGGTGGTGTTTGTCCCCGCAGGCACTCACACTCCTGGGAGCCGGCTCCAGTCAGAAAAGCCACGAGGCTTTGCTCGAGGTTTGGAG CCGGAGCGGATTATTGGAGCTACAGACTCCAGTGGAGAGCTCATGTTCCTGATGAAATGGTGAGTCGGCCAGTGGCTCTGTGTGGTTGTT |
Top |
FusionGenePPI for SCRN2_CBX1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| SCRN2 | TERF2IP, TINF2, NFKBIA, TAS2R41, CAMK2D, CCS, XRN1, FAM122B, DCAF10, PRRC2B, KCTD3, XYLB, MARCKSL1, PDPK1, SOX2 | CBX1 | C11orf30, DNMT1, DNMT3A, RB1, SUV39H1, RPL12, UCHL1, LRIF1, TRIM28, CBX1, CBX3, CBX5, PIM1, ARL5A, SP100, BAP1, USP17L2, MYOD1, BANF1, EHMT2, CHD1L, SUV420H2, HIST1H3A, H3F3A, ZNF382, DNMT3B, HIST3H3, NSL1, CHD4, POGZ, ADNP, ADNP2, XRCC6, CHAF1A, H2AFB1, HIST1H4F, PCNA, MECP2, KLF11, HIST1H3B, TRIM39, VTN, ABI3BP, NR2F6, VHL, PARK2, PRDM6, ZNF280D, AHDC1, CHAMP1, THRAP3, CUL7, OBSL1, RNF2, SUV39H2, HSPB1, IFI16, HIST1H3E, MAU2, H2AFY, BRCA1, BARD1, NFATC2, DUSP8, PCGF6, PRR14, VDAC1, G3BP1, GTF2IRD1 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for SCRN2_CBX1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for SCRN2_CBX1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | CBX1 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|